Polish Survey on the Efficacy of the Hypercholesterolemia Treatment

Centralized Pan-European Survey on the Undertreatment of Hypercholesterolemia. Polish Survey on the Efficacy of the Hypercholesterolemia Treatment

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01243255

Acronym

CEPHEUS

Enrollment

1500

Registered

2010-11-18

Start date

2010-12-31

Completion date

2011-06-30

Last updated

2012-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypercholesterolemia

Keywords

hypercholesterolemia, low density lipoprotein, undertreatment of hypercholesterolemia

Brief summary

The purpose of the survey is to evaluate the efficacy of treatment of hypercholesterolemia in Polish patients who are currently on lipid- lowering pharmacological therapy . Efficient treatment is defined as achievement of the LDL cholesterol level goals according to the European Society of Cardiology 2007 guidlines.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients on lipid lowering drug treatment * Lipid lowering drug treatment lasting at least 3 months * No lipid lowering drug/dose change for a minimum 6 weeks prior to enrolment to the study

Exclusion criteria

* Lack of patient's signed informed consent form * Lack of the blood sample taken for lipid profile and glucose within 10 days before or after assessment of the patient

Design outcomes

Primary

Measure	Time frame
establish the proportion of patients on lipid lowering pharmacological treatment reaching the LDL-C goals according to ESC 2007 guidelines in general.	whole study procedure takes place during the one, single patient's visit

Secondary

Measure	Time frame
establish the proportion of patients on lipid lowering pharmacological treatment in primary prevention, reaching the LDL-C goals according to ESC 2007 guidelines for this sub-population	whole study procedure takes place during the one, single patient's visit
establish the proportion of patients on lipid lowering pharmacological treatment in secondary prevention, reaching the LDL-C goals according to ESC 2007 guidelines for this sub-population	whole study procedure takes place during the one, single patient's visit
identify determinants (patient and physician characteristics) for undertreatment of hypercholesterolemia.	whole study procedure takes place during the one, single patient's visit

Outcome results